Blink Health valuation, funding and investors
Blink Health works in digital pharmacy platform services, based in New York, United States. Founded in 2014, it has about 400 employees.
New York Series D
VALUATION · TODAY
$2.52B +0% after Series D
Range $1.12B – $3.83B · Grade CTODAY
+12 MO
$1.00B
$2.00B
$3.00B
$4.00B
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Series B $90.0M
Series C $205M
Series D $140M
ValuationBefore first round12-month outlook: where it points, how wide it fansHover the past: the outlook shows what was predicted then
HEADCOUNT · TODAY634 employees
+4%6m growth
+28%1y growth
+71%2y growth
250
500
750
Data from Jan 2021
Predicted in 1 yr $2.52B +0% vs today
Predicted next raise $277M if a round comes
Winding-down probability 0%
- Last round
- Series D · $140M · Nov 2024
- Valuation at last round
- $1.75B · implied
- Headcount
- 634 · up
- Grade
- C
- Founded
- 2014
Blink Health valuation today
VCMC values Blink Health at $2.5B today, with a range of $1.1B to $3.8B and a grade of C. The valuation starts from its last funding round, a Series D round in Nov 2024.
Valuation by date (158 rows)
Each point is what the model would have shown on that date, using only what was known then; before its first round, a company is valued as a startup because it later raised.
| Date | Valuation | Range | Predicted in 1 yr | Phase | Headcount | Trend | Grade | Winding-down probability |
|---|---|---|---|---|---|---|---|---|
| 1 Jan 2014 | $4.90M | $1.78M – $13.4M | $5.13M (+5%) | before first round | – | unknown | D | 0% |
| 1 Feb 2014 | $4.92M | $1.79M – $13.5M | $5.15M (+5%) | before first round | – | unknown | D | 0% |
| 1 Mar 2014 | $4.93M | $1.80M – $13.6M | $5.17M (+5%) | before first round | – | unknown | D | 0% |
| 1 Apr 2014 | $4.95M | $1.80M – $13.6M | $5.19M (+5%) | before first round | – | unknown | D | 0% |
| 1 May 2014 | $4.97M | $1.81M – $13.7M | $5.21M (+5%) | before first round | – | unknown | D | 0% |
| 1 Jun 2014 | $4.99M | $1.82M – $13.7M | $5.23M (+5%) | before first round | – | unknown | D | 0% |
| 1 Jul 2014 | $5.01M | $1.82M – $13.8M | $5.25M (+5%) | before first round | – | unknown | D | 0% |
| 1 Aug 2014 | $5.03M | $1.83M – $13.8M | $5.27M (+5%) | before first round | – | unknown | D | 0% |
| 1 Sep 2014 | $5.05M | $1.84M – $13.9M | $5.29M (+5%) | before first round | – | unknown | D | 0% |
| 1 Oct 2014 | $5.07M | $1.85M – $13.9M | $5.31M (+5%) | before first round | – | unknown | D | 0% |
| 1 Nov 2014 | $5.09M | $1.85M – $14.0M | $5.33M (+5%) | before first round | – | unknown | D | 0% |
| 1 Dec 2014 | $5.11M | $1.86M – $14.0M | $5.36M (+5%) | before first round | – | unknown | D | 0% |
| 1 Jan 2015 | $5.13M | $1.87M – $14.1M | $5.38M (+5%) | before first round | – | unknown | D | 0% |
| 1 Feb 2015 | $5.15M | $1.88M – $14.2M | $5.40M (+5%) | before first round | – | unknown | D | 0% |
| 1 Mar 2015 | $5.17M | $1.88M – $14.2M | $5.42M (+5%) | before first round | – | unknown | D | 0% |
| 1 Apr 2015 | $5.19M | $1.89M – $14.3M | $5.44M (+5%) | before first round | – | unknown | D | 0% |
| 1 May 2015 | $5.21M | $1.90M – $14.3M | $5.46M (+5%) | before first round | – | unknown | D | 0% |
| 1 Jun 2015 | $5.23M | $1.90M – $14.4M | $5.48M (+5%) | before first round | – | unknown | D | 0% |
| 1 Jul 2015 | $5.25M | $1.91M – $14.4M | $5.50M (+5%) | before first round | – | unknown | D | 0% |
| 1 Aug 2015 | $5.27M | $1.92M – $14.5M | $5.65M (+7%) | before first round | – | unknown | D | 0% |
| 1 Sep 2015 | $5.29M | $1.93M – $14.5M | $5.80M (+10%) | before first round | – | unknown | D | 0% |
| 1 Oct 2015 | $5.31M | $1.93M – $14.6M | $5.95M (+12%) | before first round | – | unknown | D | 0% |
| 1 Nov 2015 | $5.33M | $1.94M – $14.7M | $6.11M (+15%) | before first round | – | unknown | D | 0% |
| 1 Dec 2015 | $5.36M | $1.95M – $14.7M | $6.27M (+17%) | before first round | – | unknown | D | 0% |
| 1 Jan 2016 | $5.38M | $1.96M – $14.8M | $6.45M (+20%) | before first round | – | unknown | D | 0% |
| 1 Feb 2016 | $5.40M | $1.97M – $14.8M | $6.62M (+23%) | before first round | – | unknown | D | 0% |
| 1 Mar 2016 | $5.42M | $1.97M – $14.9M | $6.79M (+25%) | before first round | – | unknown | D | 0% |
| 1 Apr 2016 | $5.44M | $1.98M – $14.9M | $6.97M (+28%) | before first round | – | unknown | D | 0% |
| 1 May 2016 | $5.46M | $1.99M – $15.0M | $7.16M (+31%) | before first round | – | unknown | D | 0% |
| 1 Jun 2016 | $5.48M | $2.00M – $15.1M | $7.35M (+34%) | before first round | – | unknown | D | 0% |
| 1 Jul 2016 | $5.50M | $2.00M – $15.1M | $7.54M (+37%) | before first round | – | unknown | D | 0% |
| 1 Aug 2016 | $5.65M | $2.06M – $15.5M | $7.75M (+37%) | before first round | – | unknown | D | 0% |
| 1 Sep 2016 | $5.80M | $2.11M – $15.9M | $7.96M (+37%) | before first round | – | unknown | D | 0% |
| 1 Oct 2016 | $5.96M | $2.17M – $16.4M | $8.17M (+37%) | before first round | – | unknown | D | 0% |
| 1 Nov 2016 | $6.12M | $2.23M – $16.8M | $8.39M (+37%) | before first round | – | unknown | D | 0% |
| 1 Dec 2016 | $6.28M | $2.29M – $17.2M | $8.61M (+37%) | before first round | – | unknown | D | 0% |
| 1 Jan 2017 | $6.45M | $2.35M – $17.7M | $8.84M (+37%) | before first round | – | unknown | D | 0% |
| 1 Feb 2017 | $6.62M | $2.41M – $18.2M | $9.08M (+37%) | before first round | – | unknown | D | 0% |
| 1 Mar 2017 | $6.78M | $2.47M – $18.6M | $9.30M (+37%) | before first round | – | unknown | D | 0% |
| 1 Apr 2017 | $6.97M | $2.54M – $19.1M | $9.55M (+37%) | before first round | – | unknown | D | 0% |
| 13 Apr 2017 | $644M | $422M – $1.5B | $964M (+50%) | after a round | – | unknown | C | 0% |
| 1 May 2017 | $657M | $422M – $1.5B | $964M (+47%) | after a round | – | unknown | C | 0% |
| 1 Jun 2017 | $680M | $422M – $1.5B | $964M (+42%) | after a round | – | unknown | C | 0% |
| 1 Jul 2017 | $703M | $422M – $1.5B | $964M (+37%) | after a round | – | unknown | C | 0% |
| 1 Aug 2017 | $727M | $422M – $1.5B | $964M (+33%) | after a round | – | unknown | C | 0% |
| 1 Sep 2017 | $753M | $422M – $1.5B | $964M (+28%) | after a round | – | unknown | C | 0% |
| 1 Oct 2017 | $778M | $422M – $1.5B | $964M (+24%) | after a round | – | unknown | C | 0% |
| 1 Nov 2017 | $805M | $422M – $1.5B | $964M (+20%) | after a round | – | unknown | C | 0% |
| 1 Dec 2017 | $833M | $422M – $1.5B | $964M (+16%) | after a round | – | unknown | C | 0% |
| 1 Jan 2018 | $862M | $422M – $1.5B | $964M (+12%) | after a round | – | unknown | C | 0% |
| 1 Feb 2018 | $892M | $422M – $1.5B | $964M (+8%) | after a round | – | unknown | C | 0% |
| 1 Mar 2018 | $920M | $422M – $1.5B | $964M (+5%) | after a round | – | unknown | C | 0% |
| 1 Apr 2018 | $952M | $422M – $1.5B | $964M (+1%) | after a round | – | unknown | C | 0% |
| 1 May 2018 | $964M | $411M – $1.5B | $964M (0%) | after a round | – | unknown | C | 0% |
| 1 Jun 2018 | $964M | $393M – $1.5B | $964M (0%) | after a round | – | unknown | C | 0% |
| 1 Jul 2018 | $964M | $377M – $1.5B | $964M (0%) | after a round | – | unknown | C | 0% |
| 1 Aug 2018 | $964M | $361M – $1.5B | $964M (0%) | after a round | – | unknown | C | 0% |
| 1 Sep 2018 | $964M | $345M – $1.5B | $964M (0%) | after a round | – | unknown | C | 0% |
| 1 Oct 2018 | $964M | $331M – $1.5B | $964M (0%) | after a round | – | unknown | C | 0% |
| 1 Nov 2018 | $964M | $316M – $1.5B | $964M (0%) | after a round | – | unknown | C | 0% |
| 1 Dec 2018 | $964M | $303M – $1.5B | $964M (0%) | after a round | – | unknown | C | 0% |
| 1 Jan 2019 | $964M | $290M – $1.5B | $964M (0%) | after a round | – | unknown | C | 0% |
| 1 Feb 2019 | $964M | $277M – $1.5B | $964M (0%) | after a round | – | unknown | C | 0% |
| 1 Mar 2019 | $964M | $267M – $1.5B | $964M (0%) | after a round | – | unknown | C | 0% |
| 1 Apr 2019 | $964M | $255M – $1.5B | $964M (0%) | after a round | – | unknown | C | 0% |
| 1 May 2019 | $964M | $225M – $1.5B | $964M (0%) | after a round | – | unknown | C | 0% |
| 1 Jun 2019 | $964M | $214M – $1.5B | $964M (0%) | after a round | – | unknown | C | 0% |
| 1 Jul 2019 | $964M | $203M – $1.5B | $964M (0%) | after a round | – | unknown | C | 0% |
| 1 Aug 2019 | $964M | $193M – $1.5B | $964M (0%) | after a round | – | unknown | D | 0% |
| 1 Sep 2019 | $964M | $184M – $1.5B | $964M (0%) | after a round | – | unknown | D | 0% |
| 1 Oct 2019 | $964M | $175M – $1.5B | $964M (0%) | after a round | – | unknown | D | 0% |
| 1 Nov 2019 | $964M | $166M – $1.5B | $964M (0%) | after a round | – | unknown | D | 0% |
| 1 Dec 2019 | $964M | $158M – $1.5B | $964M (0%) | after a round | – | unknown | D | 0% |
| 1 Jan 2020 | $964M | $150M – $1.5B | $964M (0%) | after a round | – | unknown | D | 0% |
| 1 Feb 2020 | $964M | $143M – $1.5B | $964M (0%) | after a round | – | unknown | D | 0% |
| 1 Mar 2020 | $964M | $136M – $1.5B | $964M (0%) | after a round | – | unknown | D | 0% |
| 1 Apr 2020 | $964M | $129M – $1.5B | $964M (0%) | after a round | – | unknown | D | 0% |
| 1 May 2020 | $964M | $123M – $1.5B | $964M (0%) | after a round | – | unknown | D | 0% |
| 1 Jun 2020 | $964M | $117M – $1.5B | $964M (0%) | after a round | – | unknown | D | 0% |
| 1 Jul 2020 | $964M | $112M – $1.5B | $964M (0%) | after a round | – | unknown | D | 0% |
| 1 Aug 2020 | $964M | $106M – $1.5B | $964M (0%) | after a round | – | unknown | D | 0% |
| 1 Sep 2020 | $964M | $101M – $1.5B | $964M (0%) | after a round | – | unknown | D | 0% |
| 1 Oct 2020 | $964M | $95.9M – $1.5B | $964M (0%) | after a round | – | unknown | D | 0% |
| 28 Oct 2020 | $830M | $721M – $1.2B | $1.1B (+30%) | after a round | – | unknown | A | 0% |
| 1 Nov 2020 | $832M | $721M – $1.2B | $1.1B (+30%) | after a round | – | unknown | A | 0% |
| 1 Dec 2020 | $850M | $721M – $1.2B | $1.1B (+27%) | after a round | – | unknown | A | 0% |
| 1 Jan 2021 | $869M | $721M – $1.2B | $1.1B (+24%) | after a round | 230 | unknown | A | 0% |
| 1 Feb 2021 | $889M | $721M – $1.2B | $1.1B (+21%) | after a round | 230 | unknown | A | 0% |
| 1 Mar 2021 | $907M | $721M – $1.2B | $1.1B (+19%) | after a round | 230 | unknown | A | 0% |
| 1 Apr 2021 | $928M | $721M – $1.2B | $1.1B (+16%) | after a round | 230 | flat | A | 0% |
| 1 May 2021 | $948M | $721M – $1.2B | $1.1B (+14%) | after a round | 230 | flat | A | 0% |
| 1 Jun 2021 | $969M | $721M – $1.2B | $1.1B (+11%) | after a round | 230 | flat | A | 0% |
| 1 Jul 2021 | $990M | $721M – $1.2B | $1.1B (+9%) | after a round | 230 | flat | A | 0% |
| 1 Aug 2021 | $1.0B | $721M – $1.2B | $1.1B (+6%) | after a round | 230 | flat | A | 0% |
| 1 Sep 2021 | $1.0B | $721M – $1.2B | $1.1B (+4%) | after a round | 230 | flat | A | 0% |
| 1 Oct 2021 | $1.1B | $721M – $1.2B | $1.1B (+2%) | after a round | 230 | flat | A | 0% |
| 1 Nov 2021 | $1.1B | $716M – $1.2B | $1.1B (0%) | after a round | 230 | flat | A | 0% |
| 1 Dec 2021 | $1.1B | $684M – $1.2B | $1.1B (0%) | after a round | 230 | flat | A | 0% |
| 1 Jan 2022 | $1.1B | $653M – $1.2B | $1.1B (0%) | after a round | 230 | flat | B | 0% |
| 1 Feb 2022 | $1.1B | $701M – $1.3B | $1.1B (0%) | after a round | 260 | up | A | 0% |
| 1 Mar 2022 | $1.1B | $695M – $1.3B | $1.1B (0%) | after a round | 260 | up | B | 0% |
| 1 Apr 2022 | $1.1B | $689M – $1.3B | $1.1B (0%) | after a round | 260 | up | B | 0% |
| 1 May 2022 | $1.1B | $683M – $1.3B | $1.1B (0%) | after a round | 260 | up | B | 0% |
| 1 Jun 2022 | $1.1B | $677M – $1.3B | $1.1B (0%) | after a round | 260 | up | B | 0% |
| 1 Jul 2022 | $1.1B | $671M – $1.3B | $1.1B (0%) | after a round | 260 | up | B | 0% |
| 1 Aug 2022 | $1.1B | $665M – $1.3B | $1.1B (0%) | after a round | 260 | up | B | 0% |
| 1 Sep 2022 | $1.1B | $659M – $1.3B | $1.1B (0%) | after a round | 260 | up | B | 0% |
| 1 Oct 2022 | $1.1B | $653M – $1.3B | $1.1B (0%) | after a round | 260 | up | B | 0% |
| 1 Nov 2022 | $1.1B | $403M – $1.3B | $1.1B (0%) | after a round | 260 | unknown | B | 0% |
| 1 Dec 2022 | $1.1B | $384M – $1.3B | $1.1B (0%) | after a round | 260 | unknown | B | 0% |
| 1 Jan 2023 | $1.1B | $365M – $1.3B | $1.1B (0%) | after a round | 260 | unknown | C | 0% |
| 1 Feb 2023 | $1.1B | $347M – $1.3B | $1.1B (0%) | after a round | 260 | unknown | C | 0% |
| 1 Mar 2023 | $1.1B | $331M – $1.3B | $1.1B (0%) | after a round | 260 | unknown | C | 0% |
| 1 Apr 2023 | $1.1B | $315M – $1.3B | $1.1B (0%) | after a round | 260 | unknown | C | 0% |
| 1 May 2023 | $1.1B | $541M – $1.3B | $1.1B (-3%) | after a round | 290 | up | B | 0% |
| 1 Jun 2023 | $1.1B | $531M – $1.3B | $1.1B (-4%) | after a round | 290 | up | B | 0% |
| 1 Jul 2023 | $1.1B | $521M – $1.3B | $1.1B (-4%) | after a round | 290 | up | B | 0% |
| 1 Aug 2023 | $1.1B | $512M – $1.3B | $1.1B (-5%) | after a round | 290 | up | B | 0% |
| 1 Sep 2023 | $1.1B | $251M – $1.3B | $1.1B (0%) | after a round | 290 | unknown | C | 0% |
| 1 Oct 2023 | $1.1B | $241M – $1.3B | $1.1B (-8%) | after a round | 300 | flat | C | 0% |
| 1 Nov 2023 | $1.1B | $229M – $1.3B | $1.0B (-8%) | after a round | 300 | flat | C | 0% |
| 1 Dec 2023 | $1.1B | $218M – $1.3B | $1.0B (-8%) | after a round | 300 | flat | C | 0% |
| 1 Jan 2024 | $1.1B | $207M – $1.3B | $1.0B (-8%) | after a round | 300 | flat | C | 0% |
| 1 Feb 2024 | $1.1B | $197M – $1.3B | $1.0B (-8%) | after a round | 300 | flat | C | 0% |
| 1 Mar 2024 | $1.2B | $349M – $1.3B | $1.1B (-5%) | after a round | 340 | up | C | 0% |
| 1 Apr 2024 | $1.2B | $338M – $1.3B | $1.1B (-5%) | after a round | 340 | up | C | 0% |
| 1 May 2024 | $1.1B | $328M – $1.3B | $1.1B (-5%) | after a round | 340 | up | C | 0% |
| 1 Jun 2024 | $1.1B | $317M – $1.3B | $1.1B (-5%) | after a round | 340 | up | C | 0% |
| 1 Jul 2024 | $1.1B | $307M – $1.3B | $1.1B (-5%) | after a round | 340 | up | C | 0% |
| 1 Aug 2024 | $1.2B | $303M – $1.4B | $1.2B (-1%) | after a round | 370 | up | C | 0% |
| 1 Sep 2024 | $1.2B | $293M – $1.4B | $1.2B (-1%) | after a round | 370 | up | C | 0% |
| 1 Oct 2024 | $1.2B | $284M – $1.4B | $1.2B (-1%) | after a round | 370 | up | C | 0% |
| 1 Nov 2024 | $1.2B | $559M – $1.4B | $1.2B (0%) | after a round | 400 | growing | B | 0% |
| 17 Nov 2024 | $1.8B | $1.1B – $3.5B | $2.3B (+30%) | after a round | 400 | up | B | 0% |
| 1 Dec 2024 | $1.8B | $1.1B – $3.5B | $2.3B (+29%) | after a round | 400 | up | B | 0% |
| 1 Jan 2025 | $1.8B | $1.1B – $3.5B | $2.3B (+26%) | after a round | 400 | up | B | 0% |
| 1 Feb 2025 | $1.8B | $1.1B – $3.5B | $2.3B (+23%) | after a round | 400 | up | B | 0% |
| 1 Mar 2025 | $1.9B | $1.1B – $3.5B | $2.3B (+21%) | after a round | 400 | up | B | 0% |
| 1 Apr 2025 | $1.9B | $1.1B – $3.5B | $2.3B (+18%) | after a round | 400 | up | B | 0% |
| 1 May 2025 | $2.0B | $1.1B – $3.5B | $2.3B (+15%) | after a round | 400 | up | B | 0% |
| 1 Jun 2025 | $2.0B | $1.1B – $3.5B | $2.3B (+13%) | after a round | 400 | up | B | 0% |
| 1 Jul 2025 | $2.1B | $1.2B – $3.6B | $2.4B (+12%) | after a round | 488 | growing | B | 0% |
| 1 Aug 2025 | $2.2B | $1.2B – $3.6B | $2.4B (+10%) | after a round | 495 | growing | B | 0% |
| 1 Sep 2025 | $2.2B | $1.2B – $3.6B | $2.4B (+7%) | after a round | 495 | growing | B | 0% |
| 1 Oct 2025 | $2.3B | $1.2B – $3.6B | $2.4B (+4%) | after a round | 495 | up | B | 0% |
| 1 Nov 2025 | $2.4B | $1.2B – $3.7B | $2.4B (+1%) | after a round | 547 | growing | B | 0% |
| 1 Dec 2025 | $2.4B | $1.2B – $3.7B | $2.4B (0%) | after a round | 547 | growing | B | 0% |
| 1 Jan 2026 | $2.4B | $1.2B – $3.7B | $2.4B (0%) | after a round | 547 | growing | B | 0% |
| 1 Feb 2026 | $2.4B | $1.2B – $3.7B | $2.4B (0%) | after a round | 547 | growing | B | 0% |
| 1 Mar 2026 | $2.4B | $1.3B – $3.7B | $2.4B (0%) | after a round | 547 | growing | B | 0% |
| 1 Apr 2026 | $2.5B | $1.3B – $3.8B | $2.5B (0%) | after a round | 611 | growing | B | 0% |
| 1 May 2026 | $2.5B | $1.3B – $3.8B | $2.5B (0%) | after a round | 634 | growing | B | 0% |
| 1 Jun 2026 | $2.5B | $1.2B – $3.8B | $2.5B (0%) | after a round | 634 | up | B | 0% |
| 1 Jul 2026 | $2.5B | $1.2B – $3.8B | $2.5B (0%) | after a round | 634 | up | B | 0% |
| 1 Aug 2026 | $2.5B | $1.2B – $3.8B | $2.5B (0%) | after a round | 634 | up | B | 0% |
| 1 Sep 2026 | $2.5B | $1.1B – $3.8B | $2.5B (0%) | after a round | 634 | up | C | 0% |
| 1 Oct 2026 | $2.5B | $1.1B – $3.8B | $2.5B (0%) | after a round | 634 | up | C | 0% |
| 24 Oct 2026 | $2.5B | $1.1B – $3.8B | $2.5B (0%) | after a round | 634 | up | C | 0% |
Key facts about Blink Health
- Founded
- 2014
- Headquarters
- New York, United States
- Employees
- about 400 +33% in a year
- Total raised
- $435M
- Funding rounds
- 3
- Last round
- Series D Nov 2024
Blink Health was founded in 2014 by Geoffrey Chaiken and Matthew Chaiken.
Blink Health funding history
Blink Health has 3 funding rounds on record, from Apr 2017 to Nov 2024, $435M in total. The latest disclosed valuation is $829M post-money (Series C, Oct 2020).
Series D 16 Nov 2024
Led by 1789 Capital.
$140M
$205M
$829M post-money
$90M
Blink Health investors
5 investors have backed Blink Health; 1789 Capital, 8VC and SuRo Capital led at least one round.
- 1789 Capital lead
- 8VC lead
- SuRo Capital lead
- Sweetwater Capital Partners
What Blink Health does
Blink Health works in drug stores & pharmacies, with 8 recorded offerings and customers in healthcare.
Blink Health Administration LLC is a United States healthcare technology company engaged in providing digital pharmacy solutions, including prescription lifecycle management, discounted prescription medications, and mail-order services for cash-pay medications. The company serves patients, healthcare providers, and pharmaceutical companies, primarily within the United States. Blink Health operates a network of licensed pharmacies and third-party providers to support its services.
Description from Veridion's company data.
Products and services
- Digital Pharmacy Platform Services
- Prescription Lifecycle Management Services
- Mail-Order Cash-Pay Medication Services
- Prescription Medication Delivery Services
- Mobile Healthcare Application Services
- Online Healthcare Platform Services
- Healthcare Provider Network Integration Services
- Pharmaceutical Partnership Services
Markets
- Healthcare
Business model
- Business-to-Consumer
- Service Provider
- Retail
- E-commerce
Industry codes (NAICS)
- 456110 Pharmacies and Drug Retailers 70% match
- 621999 All Other Miscellaneous Ambulatory Health Care Services 30% match
Questions about Blink Health
What is Blink Health worth?
Valuation $2.5B (range $1.1B to $3.8B), as of 24 Oct 2026. The last disclosed valuation was $829M (Series C, Oct 2020).
Has Blink Health raised money?
Blink Health has 3 funding rounds on record, from Apr 2017 to Nov 2024, $435M in total. The latest disclosed valuation is $829M post-money (Series C, Oct 2020).
Who has invested in Blink Health?
1789 Capital, 8VC, SuRo Capital, K Fund and Sweetwater Capital Partners. Lead investors include 1789 Capital, 8VC and SuRo Capital.
How many people work at Blink Health?
About 400, up 33% over the last year. Headcount grew from 230 in Jan 2021 to 634 in May 2026.
What does Blink Health do?
Blink Health works in drug stores & pharmacies, with 8 recorded offerings and customers in healthcare. Its main offerings are digital pharmacy platform services, prescription lifecycle management services and mail-order cash-pay medication services.
When was Blink Health founded, and where is it based?
Blink Health was founded in 2014 and is based in New York, United States. It has about 400 employees, up 33% over the last year.